Exact Mass: 588.4389659999999

Exact Mass Matches: 588.4389659999999

Found 172 metabolites which its exact mass value is equals to given mass value 588.4389659999999, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-(tridecanoyloxy)propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0)

(2S)-3-Hydroxy-2-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/13:0)

(2S)-2-Hydroxy-3-(tridecanoyloxy)propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0)

(2S)-3-hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-13:0)

(2S)-2-hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(10-methyldodecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0)

(2S)-3-Hydroxy-2-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(a-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-13:0)

(2S)-2-Hydroxy-3-[(10-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid

C36H60O6 (588.4389659999999)


DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,14Z,16E,18R)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,14Z,16E,18S)-18-hydroxyicosa-5,8,11,14,16-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

(2S)-1-hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

(2R)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,13E,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,11Z,17Z)-16-hydroxyicosa-5,8,11,13,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0)

(2S)-3-hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-13:0)

(2S)-2-hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (5Z,8Z,10E,14Z,17Z)-12-hydroxyicosa-5,8,10,14,17-pentaenoate

C36H60O6 (588.4389659999999)


DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

(2S)-1-Hydroxy-3-[(11-methyldodecanoyl)oxy]propan-2-yl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0)

(2S)-3-Hydroxy-2-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

(2R)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(i-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-13:0)

(2S)-2-Hydroxy-3-[(11-methyldodecanoyl)oxy]propyl (6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid

C36H60O6 (588.4389659999999)


DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Basilimoside

(2R,3R,4S,5S,6R)-2-{[(1S,2R,5S,10S,11S,14R,15R)-14-[(2R,3E)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


Basilimoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Basilimoside can be found in sweet basil, which makes basilimoside a potential biomarker for the consumption of this food product.

   
   

alpha-amyrin-3-O-beta-D-glucopyranoside

alpha-amyrin-3-O-beta-D-glucopyranoside

C36H60O6 (588.4389659999999)


   
   

peruvianursenyl glucoside|urs-12-en-18alphaH-3beta-O-beta-D-glucopyranoside

peruvianursenyl glucoside|urs-12-en-18alphaH-3beta-O-beta-D-glucopyranoside

C36H60O6 (588.4389659999999)


   

(3beta,18alpha,19alpha)-urs-20(30)-en-3-yl beta-D-glucopyranoside|3-O-beta-D-glucopyranosyltaraxasterol|taraxasterol-3-O-beta-D-glucoside

(3beta,18alpha,19alpha)-urs-20(30)-en-3-yl beta-D-glucopyranoside|3-O-beta-D-glucopyranosyltaraxasterol|taraxasterol-3-O-beta-D-glucoside

C36H60O6 (588.4389659999999)


   

beta-amyrin- beta-D-glucopyranoside|beta-amyrin-beta-D-glucopyranoside

beta-amyrin- beta-D-glucopyranoside|beta-amyrin-beta-D-glucopyranoside

C36H60O6 (588.4389659999999)


   

24-isopropyl-5alpha-cholestane-2beta,3alpha,6alpha-triol triacetate

24-isopropyl-5alpha-cholestane-2beta,3alpha,6alpha-triol triacetate

C36H60O6 (588.4389659999999)


   
   

trinonyl benzene-1,2,4-tricarboxylate

trinonyl benzene-1,2,4-tricarboxylate

C36H60O6 (588.4389659999999)


   

DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/13:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(a-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(a-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-13:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

DG(i-13:0/20:4(6E,8Z,11Z,14Z)+=O(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

DG(i-13:0/0:0/20:4(6E,8Z,11Z,14Z)+=O(5))

C36H60O6 (588.4389659999999)


   

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-13:0)

DG(20:4(6E,8Z,11Z,14Z)+=O(5)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/13:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/13:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/13:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(a-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(a-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-13:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(a-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(a-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(a-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(a-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-13:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(a-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/a-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(a-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(a-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-13:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/a-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

DG(i-13:0/20:4(5Z,8Z,11Z,13E)+=O(15)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

DG(i-13:0/0:0/20:4(5Z,8Z,11Z,13E)+=O(15))

C36H60O6 (588.4389659999999)


   

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-13:0)

DG(20:4(5Z,8Z,11Z,13E)+=O(15)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18R))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18R)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

DG(i-13:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

DG(i-13:0/0:0/20:5(5Z,8Z,11Z,14Z,16E)-OH(18))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-13:0)

DG(20:5(5Z,8Z,11Z,14Z,16E)-OH(18)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

DG(i-13:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

DG(i-13:0/0:0/20:5(5Z,8Z,10E,14Z,17Z)-OH(12))

C36H60O6 (588.4389659999999)


   

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-13:0)

DG(20:5(5Z,8Z,10E,14Z,17Z)-OH(12)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

DG(i-13:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0)

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/i-13:0/0:0)

C36H60O6 (588.4389659999999)


   

DG(i-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

DG(i-13:0/0:0/20:5(6E,8Z,11Z,14Z,17Z)-OH(5))

C36H60O6 (588.4389659999999)


   

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-13:0)

DG(20:5(6E,8Z,11Z,14Z,17Z)-OH(5)/0:0/i-13:0)

C36H60O6 (588.4389659999999)


   

(2-nonanoyloxy-3-octanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

(2-nonanoyloxy-3-octanoyloxypropyl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C36H60O6 (588.4389659999999)


   

TG(33:4)

TG(16:0_6:0_11:4)

C36H60O6 (588.4389659999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

7,8-bis(acetyloxy)-1-(5-isopropyl-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

7,8-bis(acetyloxy)-1-(5-isopropyl-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C36H60O6 (588.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6br,8ar,12s,12ar,12br,14ar,14br)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(3s,4ar,6ar,6br,8ar,12s,12ar,12br,14ar,14br)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,3e,5r)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

2-{[1-(5-ethyl-6,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[1-(5-ethyl-6,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,3r,6s,7s,8s,11s,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,3r,6s,7s,8s,11s,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

2-[(4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[(4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-hexadecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

4-[(4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-2,3,5-triol

4-[(4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl)oxy]-6-(hydroxymethyl)oxane-2,3,5-triol

C36H60O6 (588.4389659999999)


   

(1r,3as,3bs,5s,5as,7s,8s,9ar,9bs,11ar)-7,8-bis(acetyloxy)-1-[(2r)-5-isopropyl-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

(1r,3as,3bs,5s,5as,7s,8s,9ar,9bs,11ar)-7,8-bis(acetyloxy)-1-[(2r)-5-isopropyl-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-5-yl acetate

C36H60O6 (588.4389659999999)


   

2-(hydroxymethyl)-6-{[7,12,16-trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

2-(hydroxymethyl)-6-{[7,12,16-trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3r,4s,5r,6r)-4-{[(3r,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

(2r,3r,4s,5r,6r)-4-{[(3r,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,3r,6s,7s,8r,11r,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(1s,3r,6s,7s,8r,11r,12s,15r,16r)-7,12,16-trimethyl-15-[(2r)-6-methyl-5-methylideneheptan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]oxy}oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(3r,4s,5s,6r)-2-{[(3ar,3bs,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-3b,9a,11a-trimethyl-1h,2h,3h,3ah,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(3r,4s,5s,6r)-2-{[(3ar,3bs,9ar,9bs,11ar)-1-[(2r,3e,5s)-5-ethyl-6-methylhept-3-en-2-yl]-3b,9a,11a-trimethyl-1h,2h,3h,3ah,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3r,4s,5r,6r)-4-{[(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

(2r,3r,4s,5r,6r)-4-{[(3s,4ar,6ar,6bs,8ar,12ar,14ar,14br)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-6-(hydroxymethyl)oxane-2,3,5-triol

C36H60O6 (588.4389659999999)


   

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,3e,5r)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2s,3e,5r)-5-ethyl-6,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H60O6 (588.4389659999999)